The Journal of Pediatrics of Korean Medicine (대한한방소아과학회지)

The Association of Korean Oriental Pediatrics (대한한방소아과학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Oligoarticular Juvenile Idiopathic Arthritis with Oriental Medication and DMARDs & NSAIDs Tapering

소수관절형 소아기 류마티스관절염의 항류마티스제 감량과 한약투여 병행을 통한 치료사례

  • Received : 2013.10.25
  • Accepted : 2013.11.14
  • Published : 2013.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives This study is to report a case that has an effective result to oligoarticular type juvenile idiopathic arthritis patient with the oriental medicine treatment. Methods We treated the patient with an oriental medicine and tapered down with the DMARDs and NSAIDs. We followed up the laboratory blood tests every four or five months and throughout the experiment. Results The symptoms of oligoarticular type juvenile idiopathic arthritis were vanished and the patient maintained her good health condition with oriental medicine treatment after discontinued all Disease-Modifying Antirheumatic Drugs (DMARDs) and NSAIDs (Non-Steroidal Anti-Inflammatory Drugs). Her ESR, CRP levels were stable in normal and other blood test results were back to normal range. Her joint mobility and condition was back to normal. Now she is in clinical remission status. Conclusions According to the result, the oriental medicine treatment is considered to be effective on the oligoarticular juvenile idiopathic arthritis and further studies will be needed with more cases.

Keywords

References

  1. Kim DS. Juvenile Rheumatoid Arthritis. Korea Journal of Pediatrics. 2007;50(12):1173-9. https://doi.org/10.3345/kjp.2007.50.12.1173
  2. Han YS, Kim JK. A Clinical Study in Pauciarticular Juvenile Rheumatoid Arthritis. Department of Pediatrics. 1995;38(3):387.
  3. Clinic Rheumatology Compilation Committee. Clinic Rheumatology. 1st Edition. Seoul:Hankook Medical Publishing. 2006:292-309.
  4. Yi GN, Kwon OH. Clinical Pathology File. Third Edition. Seoul: Eui-Hak Publishing & Printing Co.. 2003:1055-68.
  5. Methotrexate Official FDA Information, side effects and uses. Data sources include MicromedexTM (updated Oct 7th, 2013), Cerner MultumTM (updated Sep 16th, 2013), Wolters KluwerTM (updated Oct 7th, 2013) and others. Copyright ${\copyright}$ 2000-2013 Drugs.com. http://www.drugs.com/pro/methotrexate.html
  6. Clinic Rheumatology Compilation Committee. Clinic Rheumatology. 1st Edition. Seoul:Hankook Medical Publishing. 2006:310.
  7. Severine Guillaume, Anne-Marie Prieur, Joel Coste, Chantal Job-Deslandr. Long-Term Outcome and Prognosis in Oligoarticular-Onset Juvenile Idiopathic Arthritis. Arthritis & Rheumatism. 2000;43(8):1858-65. https://doi.org/10.1002/1529-0131(200008)43:8<1858::AID-ANR23>3.0.CO;2-A
  8. Lee SW. Hidden Questions on Methotrexate. Journal of the Korean Rheumatism Association. 2012;19(1): 11-8.
  9. Hur J. Dongyuibogam. Seoul: Yogang Publishing Co.. 2003:2358.
  10. Hur J. Dongyuibogam. Seoul: Yogang Publishing Co.. 2003:2569.
  11. Doo HK, Ahn SY. Effects of Sosihotanghapsaryeungsan on Immune Response and Urination in HgCl2 Induced Renal Failure Animals. Journal of Kyung Hee Univ Med Center. 1989;5(2):158-67.
  12. Yoo CK, Lee YJ. A Case Report of Systemic Type Juvenile Rheumatoid Arthritis with Fever and Eruption. J Korean Orient Pediatr. 2009;23(1):73-83.
  13. Hanawa Toshihiko. Kanpo Shinryo No Ressun. Seoul: Korea Medical Publishing Co.. 2001:131-51